Iron Horse Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Iron Horse Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$965	Hold	4	–	–	﹤0.01%	520
2025 Q1	$974	Hold	4	–	–	﹤0.01%	513
2024 Q4	$1.31K	Hold	4	–	–	﹤0.01%	418
2024 Q3	$1.34K	Hold	4	–	–	﹤0.01%	415
2024 Q2	$1.09K	Hold	4	–	–	﹤0.01%	405
2024 Q1	$1.38K	Hold	4	–	–	﹤0.01%	377
2023 Q4	$1.29K	Hold	4	–	–	﹤0.01%	404
2023 Q3	$1.43K	Buy	+4	New	+$1.54K	﹤0.01%	395

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Iron Horse Wealth Management's BIO Position: Q2 2025 in Review

Iron Horse Wealth Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2025 at 4 shares worth $965. The position accounts for ﹤0.01% of the portfolio, ranked #520.

Iron Horse Wealth Management first reported a position in BIO in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.43K in Q3 2023. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Iron Horse Wealth Management held 4 shares of Bio-Rad Laboratories Class A worth $965 as of Q2 2025.
Iron Horse Wealth Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2025.
Bio-Rad Laboratories Class A made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #520 holding.
Iron Horse Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q3 2023 and has held it in 8 quarters since.
Iron Horse Wealth Management's Bio-Rad Laboratories Class A position peaked at $1.43K in Q3 2023.
383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.